Radioimmunoassay of antibiotics and chemotherapeutic agents.
Theapeutic monitoring of drugs has become of major importance and has stimulated development of new assay systems. Chemotherapeutic agents, many of which are toxic, have until recently been assayed by microbiological systems or other complex techniques that are impractical for a clinical laboratory. Radioimmunoassays have now been developed for some of these agents. We review the techniques for producing hapten protein conjugates and radiolabeling at specific sites on the drug molecule, and the use of these assays in clinical medicine and pharmacology.
D000900:Anti-Bacterial Agents / Q000032:analysis*; D003429:Cross Reactions; D003630:Daunorubicin / Q000032:analysis; D004317:Doxorubicin / Q000032:analysis; D005493:Folic Acid Antagonists / Q000032:analysis; D005839:Gentamicins / Q000032:analysis; D006241:Haptens; D006801:Humans; D007538:Isoniazid / Q000032:analysis; D007553:Isotope Labeling; D010406:Penicillins / Q000032:analysis; D004364:Pharmaceutical Preparations / Q000032:analysis*; D011485:Protein Binding; D011863:Radioimmunoassay / Q000379:methods; D012710:Serum Albumin, Bovine; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D005839:Gentamicins; D006241:Haptens; D010406:Penicillins; D004364:Pharmaceutical Preparations; D012710:Serum Albumin, Bovine; D004317:Doxorubicin; D007538:Isoniazid; D003630:Daunorubicin